Skip to main content
Livermore
Livermore
ZHEN

Birchview Capital, LP

SEC CIK
0001618205
Latest filing
Aug 14, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by Birchview Capital, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of FOLD by Birchview Capital, LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−253,000−100.0%Sold outHolders
Q4 2025253,000$3.60M2.1%00.0%UnchangedHolders
Q3 2025253,000$1.99M1.5%+225,000+803.6%AddedHolders
Q2 202528,000$160.4K0.2%00.0%UnchangedHolders
Q1 202528,000$228.5K0.2%00.0%UnchangedHolders
Q4 202428,000$263.8K0.2%00.0%UnchangedHolders
Q3 202428,000$299.0K0.3%00.0%UnchangedHolders
Q2 202428,000$277.8K0.3%00.0%UnchangedHolders
Q1 202428,000$329.8K0.3%00.0%UnchangedHolders
Q4 202328,000$397.3K0.3%00.0%UnchangedHolders
Q3 202328,000$340.5K0.3%00.0%UnchangedHolders
Q2 202328,000$351.7K0.3%00.0%UnchangedHolders
Q1 202328,000$311.0K0.2%00.0%UnchangedHolders
Q4 202228,000$342.0K0.2%−10,000−26.3%ReducedHolders
Q3 202238,000$397.0K0.3%00.0%UnchangedHolders
Q2 202238,000$408.0K0.3%00.0%UnchangedHolders
Q1 202238,000$360.0K0.3%00.0%UnchangedHolders
Q4 202138,000$439.0K0.3%00.0%UnchangedHolders
Q3 202138,000$363.0K0.2%00.0%UnchangedHolders
Q2 202138,000$366.0K0.2%00.0%UnchangedHolders
Q1 202138,000$375.0K0.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.